Cogent Biosciences, Inc. COGT Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s deferred tax assets and other non-current assets?
- Cogent Biosciences, Inc. (COGT) reported deferred tax assets and other non-current assets of $1.94M in Q1 2026.
- How has Cogent Biosciences, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Cogent Biosciences, Inc.'s deferred tax assets and other non-current assets decreased by 60.1% year-over-year, from $4.86M to $1.94M.
- What is the long-term trend for Cogent Biosciences, Inc.'s deferred tax assets and other non-current assets?
- Over 4 years (2021 to 2025), Cogent Biosciences, Inc.'s deferred tax assets and other non-current assets has grown at a -3.0% compound annual growth rate (CAGR), from $3.73M to $3.3M.